Healthcare providers may only recommend GLP-1 receptor agonists when BMI is over 30 (i.e., obesity), or if BMI is over 27 and the patient has an associated health condition, such as diabetes, kidney disease, or obstructive sleep apnea
IM (Intramuscular)Twice per week, in your upper thigh muscle SC (Subcutaneous) Up to 5 times per week in your belly 2 inches from your belly button
Each serving delivers 3,000mg of L-carnitine, making it a popular option for customers focused on body composition, energy support, and active lifestyle goals
Recovery science, distilled into a focused research compound
The consultation helps determine whether injectable treatment may fit the patients medical history, current medications, weight-related risk factors, and ability to safely tolerate therapy
Some people may prefer current injectable GLP-1 medications due to their potential for greater weight loss or the simplicity of weekly injections